Current Burden of Steatotic Liver Disease and Fibrosis among Adults in the United States, 2017-2023

Multi-society experts proposed the adoption of new terminology, metabolic dysfunction-associated steatotic liver disease (MASLD) and steatotic liver disease (SLD). We studied the current prevalence of SLD and its subcategories in the US.